SABRE CORP (SABR)

US78573M1045 - Common Stock

2.9  +0.03 (+1.05%)

After market: 3 +0.1 (+3.45%)

Fundamental Rating

2

Taking everything into account, SABR scores 2 out of 10 in our fundamental rating. SABR was compared to 135 industry peers in the Hotels, Restaurants & Leisure industry. SABR has a bad profitability rating. Also its financial health evaluation is rather negative. SABR is quite expensive at the moment. It does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

SABR had negative earnings in the past year.
SABR had a positive operating cash flow in the past year.
SABR had negative earnings in 4 of the past 5 years.
In multiple years SABR reported negative operating cash flow during the last 5 years.

1.2 Ratios

SABR's Return On Assets of -11.60% is on the low side compared to the rest of the industry. SABR is outperformed by 88.06% of its industry peers.
With a Return On Invested Capital value of 1.31%, SABR is not doing good in the industry: 73.13% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -11.6%
ROE N/A
ROIC 1.31%
ROA(3y)-12.92%
ROA(5y)-11.44%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

SABR's Operating Margin of 2.14% is on the low side compared to the rest of the industry. SABR is outperformed by 70.90% of its industry peers.
SABR's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 59.09%, SABR is in the better half of the industry, outperforming 67.91% of the companies in the same industry.
SABR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.14%
PM (TTM) N/A
GM 59.09%
OM growth 3YN/A
OM growth 5Y-31.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.61%
GM growth 5Y14.66%

2

2. Health

2.1 Basic Checks

SABR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for SABR has been increased compared to 1 year ago.
SABR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SABR is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -0.38, we must say that SABR is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.38, SABR is doing worse than 88.06% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.38
ROIC/WACC0.16
WACC8.33%

2.3 Liquidity

SABR has a Current Ratio of 1.27. This is a normal value and indicates that SABR is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.27, SABR is doing good in the industry, outperforming 62.69% of the companies in the same industry.
A Quick Ratio of 1.27 indicates that SABR should not have too much problems paying its short term obligations.
SABR has a Quick ratio of 1.27. This is in the better half of the industry: SABR outperforms 67.91% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27

4

3. Growth

3.1 Past

SABR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.70%, which is quite impressive.
SABR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.61%.
Measured over the past years, SABR shows a decrease in Revenue. The Revenue has been decreasing by -5.54% on average per year.
EPS 1Y (TTM)54.7%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q68.42%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y29.65%
Revenue growth 5Y-5.54%
Revenue growth Q2Q8.85%

3.2 Future

The Earnings Per Share is expected to grow by 32.71% on average over the next years. This is a very strong growth
SABR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.27% yearly.
EPS Next Y53.59%
EPS Next 2Y60.53%
EPS Next 3Y43.1%
EPS Next 5Y32.71%
Revenue Next Year4.23%
Revenue Next 2Y5.22%
Revenue Next 3Y4.71%
Revenue Next 5Y9.27%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

SABR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SABR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

75.37% of the companies in the same industry are cheaper than SABR, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 25

4.3 Compensation for Growth

SABR's earnings are expected to grow with 43.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.53%
EPS Next 3Y43.1%

0

5. Dividend

5.1 Amount

No dividends for SABR!.
Industry RankSector Rank
Dividend Yield N/A

SABRE CORP

NASDAQ:SABR (5/1/2024, 7:21:01 PM)

After market: 3 +0.1 (+3.45%)

2.9

+0.03 (+1.05%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.10B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.6%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 2.14%
PM (TTM) N/A
GM 59.09%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)54.7%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y53.59%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)14.61%
Revenue growth 3Y29.65%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y